Engineered repeated electromagnetic field shock therapy for cellular senescence and age-related diseases

Felipe P. Perez, Ximing Zhou, Jorge Morisaki, John Ilie, Todd James, Donald A. Jurivich

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A new consensus of gerontologists proposes that delay of biological senescence is the most potent public health measure for preventing chronic disease in late life. At the most fundamental level, cellular aging is characterized by a decline in repair and homeostatic systems. Thus, interventions that protect or rejuvenate these cellular systems hold significant promise for preventing or delaying the onset of age-related diseases. The most likely candidates for delaying senescence are the longevity-linked transcription factors DAF16 and HSF1. If one were to engineer negligible senescence, a key target would be the heat shock protein axis regulated by HSF1. This pathway is the preferred pathway to prevent protein damage or aggregation, whereas DAF-16/FOXO is a backup pathway activated during stress. Reduced HSF1 activity appears to accelerate tissue aging and shortens life span. Conversely, over-expression of HSF1 increases life span and decreases amyloid toxicity in animal models. This paper describes enhancement of the HSR/HSF1 pathway engineered by repeated electromagnetic field shock (REMFS). In a recent study, we demonstrated that REMFS therapy upregulates the HSR/HSF1 pathway, delays cellular senescence in young cells, and transiently reverses it in senescent cells, thus altering cellular mortality. The technology of applying certain beneficial EMF energy to the human body to stimulate the natural stress response and activate the repair and maintenance systems is a new strategy for engineered negligible senescence. We discuss the exciting clinical implications of REMFS therapy in human aging and disease.

Original languageEnglish (US)
Pages (from-to)1049-1057
Number of pages9
JournalRejuvenation Research
Volume11
Issue number6
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Convulsive Therapy
Electromagnetic Fields
Cell Aging
Heat-Shock Proteins
Human Body
Age of Onset
Amyloid
Shock
Consensus
Chronic Disease
Transcription Factors
Up-Regulation
Animal Models
Public Health
Maintenance
Technology
Mortality
Proteins

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Engineered repeated electromagnetic field shock therapy for cellular senescence and age-related diseases. / Perez, Felipe P.; Zhou, Ximing; Morisaki, Jorge; Ilie, John; James, Todd; Jurivich, Donald A.

In: Rejuvenation Research, Vol. 11, No. 6, 01.12.2008, p. 1049-1057.

Research output: Contribution to journalArticle

Perez, Felipe P. ; Zhou, Ximing ; Morisaki, Jorge ; Ilie, John ; James, Todd ; Jurivich, Donald A. / Engineered repeated electromagnetic field shock therapy for cellular senescence and age-related diseases. In: Rejuvenation Research. 2008 ; Vol. 11, No. 6. pp. 1049-1057.
@article{7f25fe582f1a49e0b597800716cc6164,
title = "Engineered repeated electromagnetic field shock therapy for cellular senescence and age-related diseases",
abstract = "A new consensus of gerontologists proposes that delay of biological senescence is the most potent public health measure for preventing chronic disease in late life. At the most fundamental level, cellular aging is characterized by a decline in repair and homeostatic systems. Thus, interventions that protect or rejuvenate these cellular systems hold significant promise for preventing or delaying the onset of age-related diseases. The most likely candidates for delaying senescence are the longevity-linked transcription factors DAF16 and HSF1. If one were to engineer negligible senescence, a key target would be the heat shock protein axis regulated by HSF1. This pathway is the preferred pathway to prevent protein damage or aggregation, whereas DAF-16/FOXO is a backup pathway activated during stress. Reduced HSF1 activity appears to accelerate tissue aging and shortens life span. Conversely, over-expression of HSF1 increases life span and decreases amyloid toxicity in animal models. This paper describes enhancement of the HSR/HSF1 pathway engineered by repeated electromagnetic field shock (REMFS). In a recent study, we demonstrated that REMFS therapy upregulates the HSR/HSF1 pathway, delays cellular senescence in young cells, and transiently reverses it in senescent cells, thus altering cellular mortality. The technology of applying certain beneficial EMF energy to the human body to stimulate the natural stress response and activate the repair and maintenance systems is a new strategy for engineered negligible senescence. We discuss the exciting clinical implications of REMFS therapy in human aging and disease.",
author = "Perez, {Felipe P.} and Ximing Zhou and Jorge Morisaki and John Ilie and Todd James and Jurivich, {Donald A.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1089/rej.2008.0793",
language = "English (US)",
volume = "11",
pages = "1049--1057",
journal = "Rejuvenation Research",
issn = "1549-1684",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Engineered repeated electromagnetic field shock therapy for cellular senescence and age-related diseases

AU - Perez, Felipe P.

AU - Zhou, Ximing

AU - Morisaki, Jorge

AU - Ilie, John

AU - James, Todd

AU - Jurivich, Donald A.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - A new consensus of gerontologists proposes that delay of biological senescence is the most potent public health measure for preventing chronic disease in late life. At the most fundamental level, cellular aging is characterized by a decline in repair and homeostatic systems. Thus, interventions that protect or rejuvenate these cellular systems hold significant promise for preventing or delaying the onset of age-related diseases. The most likely candidates for delaying senescence are the longevity-linked transcription factors DAF16 and HSF1. If one were to engineer negligible senescence, a key target would be the heat shock protein axis regulated by HSF1. This pathway is the preferred pathway to prevent protein damage or aggregation, whereas DAF-16/FOXO is a backup pathway activated during stress. Reduced HSF1 activity appears to accelerate tissue aging and shortens life span. Conversely, over-expression of HSF1 increases life span and decreases amyloid toxicity in animal models. This paper describes enhancement of the HSR/HSF1 pathway engineered by repeated electromagnetic field shock (REMFS). In a recent study, we demonstrated that REMFS therapy upregulates the HSR/HSF1 pathway, delays cellular senescence in young cells, and transiently reverses it in senescent cells, thus altering cellular mortality. The technology of applying certain beneficial EMF energy to the human body to stimulate the natural stress response and activate the repair and maintenance systems is a new strategy for engineered negligible senescence. We discuss the exciting clinical implications of REMFS therapy in human aging and disease.

AB - A new consensus of gerontologists proposes that delay of biological senescence is the most potent public health measure for preventing chronic disease in late life. At the most fundamental level, cellular aging is characterized by a decline in repair and homeostatic systems. Thus, interventions that protect or rejuvenate these cellular systems hold significant promise for preventing or delaying the onset of age-related diseases. The most likely candidates for delaying senescence are the longevity-linked transcription factors DAF16 and HSF1. If one were to engineer negligible senescence, a key target would be the heat shock protein axis regulated by HSF1. This pathway is the preferred pathway to prevent protein damage or aggregation, whereas DAF-16/FOXO is a backup pathway activated during stress. Reduced HSF1 activity appears to accelerate tissue aging and shortens life span. Conversely, over-expression of HSF1 increases life span and decreases amyloid toxicity in animal models. This paper describes enhancement of the HSR/HSF1 pathway engineered by repeated electromagnetic field shock (REMFS). In a recent study, we demonstrated that REMFS therapy upregulates the HSR/HSF1 pathway, delays cellular senescence in young cells, and transiently reverses it in senescent cells, thus altering cellular mortality. The technology of applying certain beneficial EMF energy to the human body to stimulate the natural stress response and activate the repair and maintenance systems is a new strategy for engineered negligible senescence. We discuss the exciting clinical implications of REMFS therapy in human aging and disease.

UR - http://www.scopus.com/inward/record.url?scp=58149216626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149216626&partnerID=8YFLogxK

U2 - 10.1089/rej.2008.0793

DO - 10.1089/rej.2008.0793

M3 - Article

C2 - 19119860

AN - SCOPUS:58149216626

VL - 11

SP - 1049

EP - 1057

JO - Rejuvenation Research

JF - Rejuvenation Research

SN - 1549-1684

IS - 6

ER -